These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 15668873

  • 1. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
    Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M, Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.
    Clin Infect Dis; 2005 Feb 01; 40(3):468-74. PubMed ID: 15668873
    [Abstract] [Full Text] [Related]

  • 2. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.
    Dtsch Med Wochenschr; 2007 May 04; 132(18):977-82. PubMed ID: 17457780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.
    Kozal MJ, Hullsiek KH, Leduc R, Novak RM, MacArthur RD, Lawrence J, Baxter JD, Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    Antivir Ther; 2006 May 04; 11(4):457-63. PubMed ID: 16856619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, de Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJ.
    Virus Res; 2007 Nov 04; 129(2):87-90. PubMed ID: 17686543
    [Abstract] [Full Text] [Related]

  • 9. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC.
    Clin Infect Dis; 2006 Jan 15; 42(2):252-9. PubMed ID: 16355337
    [Abstract] [Full Text] [Related]

  • 10. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
    Di Giambenedetto S, Bracciale L, Colafigli M, Cattani P, Pinnetti C, Bacarelli A, Prosperi M, Fadda G, Cauda R, De Luca A.
    Antivir Ther; 2007 Jan 15; 12(5):835-9. PubMed ID: 17713168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
    Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM.
    Antivir Ther; 2001 Mar 15; 6(1):63-70. PubMed ID: 11417763
    [Abstract] [Full Text] [Related]

  • 17. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
    Lohse N, Jørgensen LB, Kronborg G, Møller A, Kvinesdal B, Sørensen HT, Obel N, Gerstoft J, Danish HIV Cohort Study.
    Antivir Ther; 2007 Mar 15; 12(6):909-17. PubMed ID: 17926645
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
    Murillo W, de Rivera IL, Parham L, Jovel E, Palou E, Karlsson AC, Albert J.
    HIV Med; 2010 Feb 15; 11(2):95-103. PubMed ID: 19686436
    [Abstract] [Full Text] [Related]

  • 19. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S, Keys JR, Quinlivan EB, Wohl DA, Mikeal OV, Eron JJ.
    AIDS; 2007 Apr 23; 21(7):825-34. PubMed ID: 17415037
    [Abstract] [Full Text] [Related]

  • 20. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R, Ananworanich J, Sirivichayakul S, Ubolyam S, Siangphoe U, Hill A, Cooper D, Lange J, Phanuphak P, Ruxrungtham K.
    Clin Infect Dis; 2005 Mar 01; 40(5):728-34. PubMed ID: 15714420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.